scholarly journals PREEMPTIVE VV ECMO RESPIRATORY SUPPORT FOR COMPLEX AIRWAY MANAGEMENT IN PATIENT UNDERGOING MAJOR SPINE SURGERY

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A77
Author(s):  
Lin Chen ◽  
Jesse Rappaport ◽  
Vivian Hua ◽  
Mani Latifi ◽  
Alejandro Bribriesco
2018 ◽  
Author(s):  
Brock Fisher ◽  
Erin Ragan-Stucky Fisher

2012 ◽  
pp. 50-60 ◽  
Author(s):  
Basem Abdelmalak ◽  
D. John Doyle

2016 ◽  
Vol 9 (4) ◽  
pp. 475-477
Author(s):  
Richard P. Fernandez ◽  
Don Hayes ◽  
Patrick I. McConnell ◽  
Darren Berman

Extracorporeal membrane oxygenation (ECMO) is an accepted treatment modality for life support refractory to conventional efforts in neonates with complex congenital heart lesions. Cannulation for ECMO can be accomplished by venovenous (VV) access where patients receive primarily respiratory support or venoarterial (VA) access which provides complete cardiopulmonary support. VV ECMO delivered by a single-vessel cannulation with a dual-chamber venous cannula allows for respiratory support while the patient remains dependent upon intrinsic cardiac function to support hemodynamics. We present a case of support of a newborn with single ventricle physiology and intraparenchymal near-atresia of the pulmonary veins using VV ECMO.


2020 ◽  
Author(s):  
Yan Liu ◽  
Guoshi Luo ◽  
Xin Qian ◽  
Chenglin Wu ◽  
Yijun Tang ◽  
...  

Abstract Object: To report the successful diagnosis and treatment of a patient with critical condition of novel coronavirus pneumonia (COVID-19) and to summarize its clinical features and airway management experience in successful treatment.Methods: Retrospectively analyzed the successful management of one case of COVID-19 with critical condition combined respiratory failure and discussed the clinical characteristics and airway management of the patient in conjunction with a review of the latest literature.Results: A patient with an anastomotic fistula after radical treatment of esophageal cancer and right-side encapsulated pyopneumothorax was admitted with cough and dyspnea and was diagnosed with novel coronavirus pneumonia and malnutrition by pharyngeal swab nucleic acid test in combination with chest CT. The patient was treated with antibiotics, antiviral and antibacterial medications, respiratory support, expectorant nebulization, and nutritional support, expressed progressive deterioration. Endotracheal intubation and mechanical ventilation were performed since the onset of the type Ⅱ respiratory failure on the 13th day of admission. The patient had persistent refractory hypercapnia after mechanical ventilation. Based on the treatment mentioned above, combined with repeated bronchoalveolar lavage by using N-acetylcysteine ​​(NAC) inhalation solution, the patient's refractory hypercapnia was gradually improved. It was cured and discharged after being given the mechanical ventilation for 26 days as well as 46 days of hospitalization, currently is surviving well.Conclusion: Patients with severe conditions of novel coronavirus pneumonia often encounter bacterial infection in their later illness-stages. They may suffer respiratory failure and refractory hypercapnia that is difficult to improve due to excessive mucus secretion leading to small airway obstruction. In addition to the use of reasonable antibiotics and symptomatic respiratory support and other treatment, timely artificial airway and repeated bronchoalveolar NAC inhalation solution lavage, expectorant and other airway management are essential for such patients.


2004 ◽  
Vol 21 (Supplement 32) ◽  
pp. 65
Author(s):  
J. M. Nieto ◽  
I. Vives ◽  
R. Seijas ◽  
E. Guerra ◽  
A. Valer ◽  
...  

2004 ◽  
Vol 16 (4) ◽  
pp. 282-286 ◽  
Author(s):  
Yoshiaki Terao ◽  
Shuhei Matsumoto ◽  
Kazunori Yamashita ◽  
Masafumi Takada ◽  
Chiaki Inadomi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document